Patents by Inventor Genevieve Laflamme

Genevieve Laflamme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD28 antibody
    Patent number: 7723482
    Abstract: An antibody or antibody fragment directed against the CD28 receptor which blocks the interaction between B7-1 or B7-2 and CD28. Methods for blocking activation via CD28, including CD28-dependent lymphocyte activation.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: May 25, 2010
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jean-Paul Soulillou, Genevieve Laflamme, Bernard Vanhove, Daniel Olive
  • Anti-Cd28 Antibody
    Publication number: 20080038273
    Abstract: The invention concerns an antibody directed against the CD28 receptor and capable of blocking CD28/B7 interaction, and proteins derived from said antibody, for use in particular to block CD28-dependent activation of lymphocytes.
    Type: Application
    Filed: December 26, 2001
    Publication date: February 14, 2008
    Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Jean-Paul Soulillou, Genevieve Laflamme, Bernard Vanhove, Daniel Olive